Harvard Bioscience, Inc. (HBIO) revenue

Revenue · fiscal 2025
$86.55M

Harvard Bioscience, Inc. (HBIO) reported revenue of $86.55M in fiscal 2025 (the year ended December 31, 2025). That is 8.1% lower than the $94.14M of fiscal 2024. Figures as of 18 Nov 2026, 12:18 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$86.55M
Change on fiscal 2024
−8.1%
Growth, 5 years
−3.3% a year
Growth, 10 years
−2.2% a year
Highest on record
$120.77Mfiscal 2018
Lowest on record
$77.41Mfiscal 2017
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Harvard Bioscience, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 3.3% a year; over ten years the rate was −2.2% a year. Across the 17 fiscal years on record (2009–2025), the highest was $120.77M in fiscal 2018 and the lowest $77.41M in fiscal 2017.

History · 17 fiscal years

Revenue by fiscal year

Harvard Bioscience, Inc. revenue, year by year

Harvard Bioscience, Inc. (HBIO) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$86.55M 8.1% down
2024$94.14M 16.1% down
2023$112.25M 1.0% down
2022$113.34M 4.7% down
2021$118.90M 16.5% up
2020$102.10M 12.1% down
2019$116.18M 3.8% down
2018$120.77M 56.0% up
2017$77.41M 25.9% down
2016$104.52M 3.8% down
2015$108.66M 0.0% up
2014$108.66M 3.3% up
2013$105.17M 5.4% down
2012$111.17M 2.1% up
2011$108.86M 0.6% up
2010$108.18M 26.1% up
2009$85.77M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on HBIO

Harvard Bioscience, Inc., figure by figure

Harvard Bioscience, Inc. (HBIO) overview: price, valuation and scorecard

Harvard Bioscience, Inc. revenue: questions and answers

What is Harvard Bioscience, Inc.'s revenue?

Harvard Bioscience, Inc. (HBIO) reported revenue of $86.55M in fiscal 2025 (the year ended December 31, 2025). That is 8.1% lower than the $94.14M of fiscal 2024.

What is the growth rate of Harvard Bioscience, Inc.'s revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 3.3% a year; over ten years the rate was −2.2% a year.

What are the highest and lowest revenue figures on record for Harvard Bioscience, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $120.77M in fiscal 2018 and the lowest $77.41M in fiscal 2017.

How is Harvard Bioscience, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Harvard Bioscience, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Harvard Bioscience, Inc. (HBIO) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/HBIO/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.